Ricardo E. Vilain
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 14
- Cutaneous Melanoma Detection and Management 9
- CAR-T cell therapy research 8
-
- Melanoma and MAPK Pathways 8
- DNA Repair Mechanisms 3
- Co-authors
- Richard A. Scolyer (19 shared papers)John F. Thompson (10 shared papers)James S. Wilmott (9 shared papers)Georgina V. Long (6 shared papers)Jason Madore (6 shared papers)Jennifer H. Yearley (4 shared papers)Hojabr Kakavand (6 shared papers)Alexander M. Menzies (5 shared papers)
- Journals
- Clinical Cancer Research (3 papers)The American Journal of Surgical Pathology (3 papers)Oncotarget (3 papers)Pathology (3 papers)Annals of Surgical Oncology (2 papers)
- Partner nations
- AustraliaUnited StatesBrazil
In The Last Decade
Ricardo E. Vilain
39 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 71
- Oncology 1.2k
- Gastroenterology 138
- Immunology 504
- Pulmonary and Respiratory Medicine 452
- Cancer Research 205
Countries citing papers authored by Ricardo E. Vilain
This map shows the geographic impact of Ricardo E. Vilain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo E. Vilain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo E. Vilain more than expected).
Fields of papers citing papers by Ricardo E. Vilain
This network shows the impact of papers produced by Ricardo E. Vilain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo E. Vilain. The network helps show where Ricardo E. Vilain may publish in the future.
Co-authors
The 25 scholars most cited alongside Ricardo E. Vilain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 333 | |
| 2 | 2015 | 236 | |
| 3 | 2017 | 191 | |
| 4 | 2010 | 150 | |
| 5 | 2015 | 115 | |
| 6 | 2016 | 92 | |
| 7 | 2012 | 85 | |
| 8 | 2015 | 73 | |
| 9 | 2016 | 44 | |
| 10 | 2016 | 39 | |
| 11 | 2016 | 31 | |
| 12 | 2013 | 20 | |
| 13 | 2015 | 20 | |
| 14 | 2017 | 18 | |
| 15 | 2019 | 17 | |
| 16 | 2016 | 14 | |
| 17 | 2018 | 12 | |
| 18 | 2018 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2015 | 9 |
About Ricardo E. Vilain
Ricardo E. Vilain is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Surgery, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Cutaneous Melanoma Detection and Management (9 papers), Melanoma and MAPK Pathways (8 papers), Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (8 papers), Cancer Genomics and Diagnostics (4 papers), DNA Repair Mechanisms (3 papers) and Nonmelanoma Skin Cancer Studies (3 papers). The work is most often cited by research in Oncology (1.2k citations), Gastroenterology (138 citations), Immunology (504 citations), Pulmonary and Respiratory Medicine (452 citations) and Cancer Research (205 citations). Ricardo E. Vilain has collaborated with scholars based in Australia, United States and Brazil. Frequent co-authors include Richard A. Scolyer, John F. Thompson, James S. Wilmott, Georgina V. Long, Jason Madore, Jennifer H. Yearley, Hojabr Kakavand, Alexander M. Menzies, Richard Kefford and Peter Hersey. Their work appears in journals such as Clinical Cancer Research, The American Journal of Surgical Pathology, Oncotarget, Pathology and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.